Cronos Group Inc (CRON)
$6.27
0.18 (2.79%)
CRON Stock Quote Delayed 30 Minutes
Previous Close
$6.27
Market Cap
1.10B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.59M
Day's Range
6.24 - 6.48
52-Week Range
4.00 - 15.85
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
Forget Legalization: CBD Is Good Enough for CRON Stock
Under conventional thinking, CRON stock can’t reach its full potential without the U.S. fully legalizing weed. But the “dumbed-down” CBD market is really what the American consumer desires, which benefits Cronos via its Lord Jones acquisition.
Organigram Stock a Standout Long-Term Winner in the Cannabis Sector
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock.
CRON Stock Could Ride the Cannabis Resurgence into a Year-Long Rally
As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.
Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
7 Stocks to Buy for January and Beyond
The outgoing 2019 was truly a year to remember, with many events that will surely carry over into 2020 and beyond. Here are the stocks to buy to advantage these developments.
U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Pair-Trading Cannabis Stocks: Go Long THC and Short CBD
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
Can Cronos Stock Break Out of Its Downtrend?
Cronos stock is surviving thanks to its large cash balance. However, can CRON stock finally turn the corner and snap out of its funk?
Cronos Group Remains a Different Kind of Cannabis Company
Although Cronos Group stock distinguishes itself in the embattled cannabis sector, it too makes some assumptions about future growth potential that may not suit all investors.
Cronos Stock Will Not Rebound Any Time Soon
With the MORE Act unlikely to pass Congress, and supply issues still plaguing Canada, you can find better opportunities elsewhere.
Cronos Stock Gets Closer to Being a Buy, but It’s Not There Yet
Cronos stock long has been the pot stock for investors who don't like pot stocks. That might be enough for a buy at some point.
Is Aurora Cannabis Stock Officially Back from the Dead?
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
Don’t Buy Cronos Stock on the U.S. House Committee Vote
CRON stock should become an eventual winner for investors, but the rally sparked by the vote in the U.S. House will likely not last.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
